INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC., VYRIAD, INC. FILES APPLICATION FOR "RECOMBINANT RHABDOVIRUS ENCODING INTERLEUKIN-12 (IL-12)"

GENEVA, Oct. 6 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591), VYRIAD, INC. (2900 37th Street, NWBuilding 110Rochester, Minnesota 55901) filed a patent application (PCT/US2025/022071) for "RECOMBINANT RHABDOVIRUS ENCODING INTERLEUKIN-12 (IL-12)" on Mar 28, 2025. With publication no. WO/2025/208054, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DADI-MEHMETAJ, Saida (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10591), MARGUERITE BAUMANN, Matt...